The hormone receptor-positive molecular subtype represents 64% of the diagnosed breast cancer cases and is characterized by the expression of estrogen receptor (ER) or progesterone receptor (PR) (ER and/or PR) [4]. Here, PGR is linked to breast carcinoma.